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Abstract 
 
 
 Individuals vary in their willingness to take financial risks.  Here we show that 
variants of two genes that regulate dopamine and serotonin neurotransmission and have 
been previously linked to emotional behavior, anxiety and addiction (5-HTTLPR and 
DRD4) are significant determinants of risk taking in investment decisions. We find that 
the 5-HTTLPR s/s allele carriers take 28% less risk than those carrying the s/l or l/l 
alleles of the gene. DRD4 7-repeat allele carriers take 25% more risk than individuals 
without the 7-repeat allele. These findings contribute to the emerging literature on the 
genetic determinants of economic behavior. 
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Introduction 
  Risk preferences describe individuals' willingness to take or avoid risk in a variety 
of settings, including financial choice, and are an essential component of any model of 
economic behavior. Individuals vary in the extent to which they are willing to take 
financial risks, which may be explained in part by individual differences in heritable traits.  
Classical twin design studies estimate that genetic effects account for 20% variation in 
risk taking in experimental lottery choices [1] and between 35-54% of the liability for 
developing symptoms of pathological gambling [2].  However, identification of specific 
genes underlying financial risk preferences has remained elusive. 
Recent findings in neuroscience suggest that the neurotransmitters dopamine [3] 
and serotonin [4] have important roles in decision making. Genes that regulate these 
neurotransmitters impact the processing of information about rewarding [5-6] and 
harmful stimuli [6-8], are related to personality traits such as extraversion [9], novelty 
seeking [10] and anxiety [11], and are associated with developing addictions [12]. 
Moreover, activity within the anterior insula and the nucleus accumbens, brain regions 
innervated by serotonergic and dopaminergic neural pathways, has been shown to relate 
to individuals’ financial risk taking behavior [13].  
Given the mounting evidence that the dopaminergic and serotonergic systems are 
involved in decision making, and that genetic variations have a significant effect on the 
physiology of these two systems [14-15], we sought to understand whether such genetic 
variations lead to individual differences in financial risk taking preferences. Prior 
research suggests that variants of two specific genes may be involved in risk and reward 
processing, and therefore could influence financial risk taking: the serotonin transporter 
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polymorphism (5-HTTLPR) and dopamine D4 receptor (DRD4) exon III polymorphism. 
The 5-HTTLPR consists of a 44-base pair insertion or deletion, generating either a long 
(l) or a short (s) allele. The short variant of the polymorphism reduces the transcriptional 
efficiency of the 5-HTT gene promoter and is associated with higher scores on 
neuroticism and harm avoidance [11].  The dopamine D4 receptor (DRD4) exon III 
polymorphism has been linked to novelty seeking and pathological gambling. Individuals 
with the 7-repeat allele have higher novelty seeking scores than those with other DRD4 
variants [10] and are more likely to be pathological gamblers [16]. 
 Here we investigated whether or not genetic variations in these two candidate 
functional polymorphisms, 5-HTTLPR and DRD4, contribute to individual differences in 
financial risk taking preferences. Based on prior work, we hypothesized that individuals 
carrying two copies of the s allele of the 5-HTTLPR would be significantly more risk 
averse relative to individuals carrying one or two copies of the l allele.  Additionally, we 
hypothesized that individuals with a 7-repeat allele of the DRD4 polymorphism would be 
significantly more risk seeking relative to those individuals without the 7-repeat allele.   
We elicited financial risk preferences in an experimental setting where 
participants made multiple investment decisions allocating funds between a risky and a 
riskless asset, and were compensated based on the performance of their chosen financial 
portfolio (Fig. 1A). We subsequently genotyped participants for 5-HTTLPR and DRD4 
functional polymorphisms (see Supplement).  
We found that individuals carrying two copies of the short allele of the 5-
HTTLPR are significantly more risk averse relative to individuals carrying one or two 
copies of the long allele. Additionally, individuals with the 7-repeat allele of DRD4 are 
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significantly more risk seeking relative to those individuals without the 7-repeat allele. 
These findings provide novel evidence of a genetic basis for financial choices. 
 
Experimental Methods 
65 subjects (26 male; M age = 22.4 yrs; SD age: 4.9 yrs) completed the 
investment task and were subsequently genotyped for the 5-HTTLPR and DRD4 
functional polymorphisms.  Genotyping was conducted by ACGT Inc. (Wheeling, IL) 
(see Supplementary Methods). 
All participants were affiliated with Northwestern University and were recruited 
via email announcements sent to the subject pool maintained by the Kellogg School of 
Management at Northwestern University. The experiment was programmed (and data 
were collected) using the software package E-Prime. Five to nine subjects were in the 
laboratory solving the investment task at the same time, with each individual in a cubicle 
separated from the rest of the participants.  Participants gave informed consent prior to 
participating and the study was approved by the IRB committee at Northwestern 
University.  The entire experiment took 1.5 hours to complete and the average pay per 
subject was $25.  
 The entire sample consisted of 21 carriers (8 male) homozygous for the s allele, 
44 carriers (18 male) with one or two copies of the l allele of the 5-HTTLPR 
polymorphism (see Supplementary Table 1), 15 carriers (8 male) of the 7-repeat allele, 
and 50 non-carriers (18 male) of 7-repeat allele variant of DRD4 (see Supplementary 
Table 2).  We conducted statistical analyses to compare expected versus observed allele 
frequencies for our 5-HTTLPR sample (see Supplementary Table 1) and found that 5-
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HTTLPR genotypes in our sample were distributed according to Hardy-Weinberg 
equilibrium (Pearson chi-square = 0.39, df = 1, p > 0.05).  Additionally, we conducted 
statistical analyses for HW equilibrium of DRD4 genotypes (see Supplementary Table 2) 
using the Markov Chain algorithm [17] and found that DRD4 allele frequencies in the 
current sample were distributed according to HWE (Markov chain algorithm; p = 0.36).   
 Participants first completed the investment task and were then genotyped.   On 
each of the 96 trials (see Fig. 1A) of the task subjects were given an amount of money $T. 
Subjects could invest $T + $15 (the show-up fee) in two assets, a riskless and a risky one. 
The amount not invested in the risky asset was automatically invested in the riskless asset 
(shorting and borrowing were not allowed). The trial endowment amount T was either $8 
or $13, and hence the amount subjects could invest (T+$15 show-up fee) was either $23 
or $28 per trial. In one version of the task, subjects were informed that the risky asset 
would pay either of two possible returns with equal probability, and these two possible 
outcomes for the return were known by the subject in each trial. In another version of the 
task, subjects were provided with the expected return and standard deviation of the risky 
asset. These two ways of presenting information about the payoffs of the risky investment 
are equivalent if subjects have mean-variance preferences (i.e. they like higher expected 
returns and lower variance), a common assumption in the finance literature which is also 
supported by our data. The riskless asset paid a known rate of return. Subjects’ choices 
did not differ across these versions of the task (completed by 26 and 39 subjects, 
respectively), and therefore we combine the data from the two versions. 
 At the time of making a choice, subjects knew the actual rate of return of the risk-
free asset and the two possible outcomes of the risky security, or, equivalently, the 
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expected value and standard deviation of the risky return.  These values differed from 
trial to trial, as did the amount of money available to the subject to invest. The actual rate 
of return for the risky asset on any trial was not revealed until the end of the experiment. 
At the end of the experiment, each subject selected a random number between 1 and 96 
by picking a ball from an urn. That number determined the trial for which the subject 
would receive payment. If on any trial a subject chose to invest in the risky asset an 
amount larger that the maximum investment allowed ($T + $15), or if they did not 
respond, that trial was marked as invalid. If an invalid trial was selected from the urn, the 
final payment was only the show-up fee of $15. Subjects therefore had incentives to 
always enter their choice for the risky investment, and to treat each of the 96 trials as the 
one that would determine their pay. By deferring information about earnings until the end 
of the experiment we eliminate wealth effects that may change subjects' choices 
depending on past outcomes. 
 In each trial subjects had six seconds to learn the information about the return 
distribution of the risky security and the return of the safe asset. They had six additional 
seconds to enter the dollar amount they wished to invest in the risky asset, which was an 
integer that could range from zero to the maximum investment of $T + $15. A 2-second 
fixation screen indicated a new trial was about to begin. 
 
Results 
 The amount of money participants invested in the risky security (M risky 
allocation: $9.78; SD risky allocation: $7.16) on each trial depended on the 
characteristics of the two investment choices, as would be predicted by standard models 
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of economic choice where individuals have mean-variance preferences [18].  Our 
benchmark model of investment decisions (see Table 1) indicates that all else equal, 
participants invested significantly more money in the risky asset if its expected return 
was higher, the standard deviation of its return was lower, or if the return of the safe asset 
was lower.  Moreover, the higher the amount available to participants, the more money 
they invested in the risky asset. For each portfolio allocation decision of our subjects we 
calculated the risky investment in excess of the amount predicted by the benchmark 
model (i.e. the residual term in the regression model in Table 1). For each subject, we 
obtained the average across all 96 trials of this residual investment. This average is the 
subject’s excess risky investment and it measures how risk seeking an individual is 
relative to the average person in the subject pool. 
Results demonstrate that financial risk seeking is correlated with the 5-HTTLPR 
and DRD4 functional polymorphisms. As shown in Fig. 1B, individuals who carry two 
copies of the short allele of the 5-HTTLPR polymorphism invest $2.69 (about 28% of the 
average risky allocation) less in the risky asset than those carrying one or two copies of 
the long allele of the genotype (p < 0.02 in a one-tailed mean comparison test), in excess 
of the benchmark model. Similarly, individuals who carry the 7-repeat allele in the DRD4 
gene invest $2.46 (about 25% of the average risky allocation) more in the risky asset than 
those lacking the 7-repeat allele (Fig. 1C, p < 0.04 in a one-tailed mean comparison test).  
 
Discussion  
Our findings show that two functional polymorphisms known to regulate serotonergic 
and dopaminergic activity in the brain are associated with individual differences in 
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financial risk-seeking behavior. Consistent with our results, a contemporaneous study 
[19] showed in a male sample a positive correlation between the presence of the 7-repeat 
allele of the D4DR and the propensity to choose risky investment options using a similar 
experimental setup. The current work complements a growing body of work 
demonstrating the heritability of economic decision-making [12, 20] and reveals specific 
genetic determinants of financial choices.  While the effects that we document here are 
suggestive of a causal relationship between individuals’ genotype and risk preferences, 
our data do not allow for causality to be firmly established. 
 
Prior work in behavioral genetics suggests an evolutionary explanation for our findings. 
For instance, a seminal study [21] found an association between long distance migration 
and the proportion of long alleles of DRD4, suggesting that DRD4 is important for 
novelty-seeking behaviors that may have adaptive value [22].  However, the strength 
association between the DRD4 gene and novelty-seeking behavior may be variable [23].  
For instance, a recent behavioral genetics study found that the presence of the 7R allele of 
the DRD4 is more advantageous among nomadic relative to settled Ariaal men living in 
northern Kenya [24].  Similarly, individuals carrying one or two copies of the short allele 
of the 5-HTTLPR have been shown to be more vulnerable to affective disorders (e.g., 
anxiety and depression) when exposed to stressful experiences [25], suggesting an 
adaptive benefit of carrying the long allele of the 5-HTTLPR.  Here we show that 
individuals who carry the long alleles of DRD4 and 5-HTTLPR take greater financial 
risks.  We speculate that financial risk taking may result from evolutionarily adaptive 
mechanisms that encourage novelty-seeking behavior, however future research is needed 
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to determine whether it leads to better economic outcomes and evolutionary benefits, 
more broadly construed. 
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Figure 1. (A) Trial structure of the investment task. For 6 seconds subjects observe the 
two possible and equally-likely values of the return of the risky asset, the return of the 
safe asset and the amount they have to invest that trial. When the word ``Choice'' appears 
on the screen, subjects have 6 seconds to enter the amount they wish to invest in the risky 
asset. Their remaining funds are automatically invested in the safe asset. A 2-second 
fixation screen precedes a new trial. (B) 5-HTTLPR and risk taking propensity.  
Individuals carrying one or two copies of the l allele demonstrated significantly greater 
risk taking relative to individuals carrying two copies of the s allele (p < 0.02).  Error bars 
indicate standard errors. (C) DRD4 and risk taking propensity.  Individuals carrying the 
7-repeat allele demonstrated significantly greater risk taking relative to individuals 
without the 7-repeat allele (p < 0.04).  Error bars indicate standard errors. 
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 Table 1. Benchmark model of amount invested in risky asset.  The dependent variable is 
the amount invested in the risky asset in each trial. Independent variables include the 
characteristics of the two investment options in a given trial, the amount of money 
available to the subject, as well as a task version indicator variable. Standard errors are 
robust to heteroscedasticity and correlation among error terms in observations belonging 
to the same subject. T-statistics are in parentheses.       
         
Dependent Variable: Amount invested in risky asset
Coefficient/t-stat
Risky Asset Expected Return 42.89
(9.20)***
Risky Asset Std. Dev. of Return -3.92
(-2.55)**
Safe Asset Return -70.01
(-7.81)***
Available funds 0.39
(7.34)***
Trial number -0.01
(-1.42)
Constant -2.66
(-1.64)
Adj. R2 0.13
Observations 5987
** p < 0.05, *** p < 0.01
 
 
 
 
 
 
 
 
 
